H
Healcerion
Mobile-based healthcare system for providing physicians and patients with ultra-portability
About Healcerion
Healcerion, founded in 2012 by Dr. Benjamin Jeongwon Ryu, a medical doctor and former astronaut candidate, is a South Korean company that has developed a portable ultrasound device, the SONON.
Dr. Ryu's background in medicine and his experience in technology, including founding a company called Digigen in 2001, led him to create Healcerion. The company aims to make medical imaging more accessible and affordable, particularly in remote or underserved areas.
Healcerion's main product, the SONON, is a handheld, wireless ultrasound scanner that connects to a smartphone or tablet. This allows for a high degree of portability and flexibility, enabling healthcare professionals to perform ultrasounds at the point of care. The device is designed for various medical applications, including abdominal, gynecological, and musculoskeletal imaging. The company offers different models, such as the SONON 300C, which is specialized for abdominal and gynecological diagnoses.
The company's business model is based on the sale of these portable ultrasound devices to a wide range of clients, including hospitals, clinics, and individual physicians. By providing a more affordable and convenient alternative to traditional ultrasound machines, Healcerion is positioned to serve a growing demand for mobile health (mHealth) solutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Seoul, South Korea
- Employees
- 16
- Open positions
- None listed
- Dealroom signal
- 72.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Ultrasound, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Mar 2019 | $18M | $73M | HB Investment · Nau IB Capital | — |
| SEED✓Equity / VC | Aug 2013 | $671K | $2.7M | SBVA | — |
Growth signals
Latest recorded traffic for Healcerion is 490 monthly website visits, down 41% over the last three months. Healcerion's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A2 investors entered at this stage
HB Investment
Nau IB Capital
Other known investors2 additional known investors
- AIAgate Medical Investments
- E&E&Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Healcerion on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Healcerion’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.